About Nextrove
Nextrove leads the industry in Life Sciences Professional Services and Solutions. Our unwavering mission, “Empowering Clients to Improve Patient Safety,” propels us on the path to realizing our vision of becoming the first choice for Life Sciences professional services and solutions, in service of our clients, partners, and, above all, the patients we ultimately serve.
We are solely dedicated to providing solutions for Pharmaceutical, Biotech, and Contract Research Organizations. As a niche consulting firm assisting clients with Pharmacovigilance, Hosting, Artificial Intelligence Solutions, eTMF, RIM, Regulatory Affairs, Clinical Operations, Medical Information, Salesforce, and Integration Services, we take pride in our unique position in the industry.
Our Progressive Suite of solutions significantly alleviates the most critical challenges in pharmacovigilance operations, with a wide range of products already in active use across numerous Pharmaceutical, Biotech, and Contract Research Organizations.
The convergence of our business proficiency and technical expertise enables us to bridge the gap between business needs and technology, exceeding the expectations of our clients. Clients unequivocally choose us because our values align with theirs: integrity, expertise, client focus, and collaboration.
With over two decades of experience, we have guided clients in adapting to the evolving regulatory landscape. Our business experts have occupied leadership roles in pharmaceutical, biotechnology, and Contract Research Organizations, while our technology leaders have spearheaded efforts in implementing safety systems.
Additionally, our readily deployable frameworks and accelerators ensure swift and efficient project delivery.
Headquartered in Princeton, New Jersey, United States, and with established offices in the UK (Leicester), Italy (Milan), Japan (Tokyo), China (Shanghai), South Korea (Seoul), and India (Noida, Bengaluru, and Mysuru), Nextrove draws from over 20 years of experience to aid our clients in meeting their global digitalization strategy, maintaining regulatory compliance, and significantly reducing the total cost of ownership across various engagements.
